Skip to main content
. 2017 Jun 15;24(14):1555–1566. doi: 10.1177/2047487317715769

Table 1.

Characteristics of the 15 publications (18 studies) included in the meta-analysis.

Study Publication, year Exposure status AFyes/AFno n/n Endpoints considered Cardiovascular diseases at baseline Study design Age, years, Mean Men (%) Follow-up, years Median
Otterstad et al.27 2006 313/7352 MI, HF, mortality Yes Cohort Retrospective 63.2 79 4.95
574/6778 MI, HF, mortality Yes Subgroup Retrospective 63.3 79 4.95
Ruigomez et al.11 2008 831/8226 CE,a HF No Cohort Retrospective 63.5 46.5 3.6
Goto et al.26 2008 713/10,850 MI, HF, mortality Yes Cohort Retrospective 69.1 49.5 1
4725/32,999 MI, HF, mortality No Subgroup Retrospective 68.3 69.9 1
Marte et al.11 2009 37/576 Major CE,b mortality Yes Cohort Prospective 62.8 67.5 4.0
Bouzas-Mosquera et al.28 2010 619/16,481 MI, mortality Yes Cohort Retrospective 64.3 59.1 6.5
Conen et al.24 2011 1011/33,711 MI, mortality No Cohort Prospective 53 0 15.4
Jabre et al.25 2011 729/2187 Mortality Yes Cohort Prospective 68 58 6.6
Bramlage et al.23 2013 455/5317 Mortality Yes Cohort Retrospective 65.2 74.6 1
Soliman et al.22 2014 1631/22,297 MI No Cohort Prospective 63.5 41.5 4.5
O’Neal et al.20 2014 434/4174 MI No Cohort Prospective 72.5 40 12.2
Chao et al.21 2014 12,114/12,114 MI No Cohort Retrospective 47.0 59.9 5.7
Andersson et al.29 2014 9519/12,468 MI, mortality, HF No Cohort – women Retrospective 67.7 0 6.5
Cohort – men Retrospective 54.9 100
Rohla et al.19 2015 146/1288 Mortality Yes Cohort Prospective 65.9 72.1 4.7
Soliman et al.5 2015 1545/12,917 MI No Cohort Prospective 54 44 21.6
Vermond et al.13 2015 265/8000 CV,c HF, mortality No Cohort Prospective 49 49.8 9.7

AF: atrial fibrillation; MI: myocardial infarction; HF: heart failure; CEs: cardiac events; CV: cardiovascular event.

a

CE defined as myocardial infarction, angina pectoris, percutaneous coronary intervention or coronary artery bypass grafting.

b

Major CE defined as coronary death and nonfatal myocardial infarction.

c

CV defined as cardiac events (acute myocardial infarction, acute and subacute ischaemic heart disease, coronary artery bypass grafting or percutaneous transluminal coronary angioplasty), cerebrovascular events (occlusion or stenosis of the precerebral or cerebral arteries or subarachnoid haemorrhage) and peripheral events (other vascular interventions such as percutaneous transluminal angioplasty or bypass grafting of the aorta and peripheral vessels).